nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—GUCY1A2—prostate gland—prostate cancer	0.0165	0.0801	CbGeAlD
Nitroglycerin—GUCY1A3—prostate gland—prostate cancer	0.0104	0.0504	CbGeAlD
Nitroglycerin—GUCY1B3—prostate gland—prostate cancer	0.0103	0.0501	CbGeAlD
Nitroglycerin—NPR1—prostate gland—prostate cancer	0.00964	0.0468	CbGeAlD
Nitroglycerin—GUCY1A3—seminal vesicle—prostate cancer	0.00878	0.0427	CbGeAlD
Nitroglycerin—ALDH2—prostate gland—prostate cancer	0.00875	0.0425	CbGeAlD
Nitroglycerin—GUCY1B3—seminal vesicle—prostate cancer	0.00871	0.0423	CbGeAlD
Nitroglycerin—NPR1—seminal vesicle—prostate cancer	0.00815	0.0396	CbGeAlD
Nitroglycerin—ALDH2—seminal vesicle—prostate cancer	0.0074	0.0359	CbGeAlD
Nitroglycerin—GUCY1A2—testis—prostate cancer	0.00726	0.0353	CbGeAlD
Nitroglycerin—NPR1—epithelium—prostate cancer	0.00708	0.0344	CbGeAlD
Nitroglycerin—GUCY1A3—renal system—prostate cancer	0.00707	0.0344	CbGeAlD
Nitroglycerin—GUCY1B3—renal system—prostate cancer	0.00702	0.0341	CbGeAlD
Nitroglycerin—GUCY1A3—urethra—prostate cancer	0.00695	0.0338	CbGeAlD
Nitroglycerin—GUCY1B3—urethra—prostate cancer	0.0069	0.0335	CbGeAlD
Nitroglycerin—NPR1—renal system—prostate cancer	0.00657	0.0319	CbGeAlD
Nitroglycerin—NPR1—urethra—prostate cancer	0.00645	0.0314	CbGeAlD
Nitroglycerin—ALDH2—renal system—prostate cancer	0.00596	0.029	CbGeAlD
Nitroglycerin—ALDH2—urethra—prostate cancer	0.00586	0.0285	CbGeAlD
Nitroglycerin—GUCY1A3—bone marrow—prostate cancer	0.00535	0.026	CbGeAlD
Nitroglycerin—GUCY1B3—bone marrow—prostate cancer	0.00531	0.0258	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—prostate cancer	0.00526	0.0256	CbGeAlD
Nitroglycerin—GUCY1A3—testis—prostate cancer	0.00457	0.0222	CbGeAlD
Nitroglycerin—GUCY1B3—testis—prostate cancer	0.00454	0.0221	CbGeAlD
Nitroglycerin—ALDH2—bone marrow—prostate cancer	0.00451	0.0219	CbGeAlD
Nitroglycerin—NPR1—testis—prostate cancer	0.00424	0.0206	CbGeAlD
Nitroglycerin—ALDH2—testis—prostate cancer	0.00385	0.0187	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—prostate cancer	0.00331	0.0161	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—prostate cancer	0.00329	0.016	CbGeAlD
Nitroglycerin—NPR1—lymph node—prostate cancer	0.00308	0.015	CbGeAlD
Nitroglycerin—ALDH2—lymph node—prostate cancer	0.00279	0.0136	CbGeAlD
Nitroglycerin—ALDH2—Biological oxidations—GSTA1—prostate cancer	0.000949	0.00359	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PRKCQ—prostate cancer	0.000941	0.00356	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTO1—prostate cancer	0.000939	0.00355	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—NAT2—prostate cancer	0.000939	0.00355	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—NOS3—prostate cancer	0.000937	0.00354	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—NOS3—prostate cancer	0.000937	0.00354	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—F9—prostate cancer	0.000923	0.00349	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GJA1—prostate cancer	0.000902	0.00341	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2C18—prostate cancer	0.0009	0.0034	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ITPR1—prostate cancer	0.000837	0.00316	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—SULT2A1—prostate cancer	0.000837	0.00316	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—NOS3—prostate cancer	0.000835	0.00315	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000827	0.00313	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGA6—prostate cancer	0.000811	0.00306	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGA6—prostate cancer	0.000811	0.00306	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—RRAS—prostate cancer	0.000806	0.00305	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.000798	0.00301	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—MDM2—prostate cancer	0.000779	0.00294	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CD9—prostate cancer	0.000762	0.00288	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CD9—prostate cancer	0.000762	0.00288	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.000761	0.00287	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—HPGDS—prostate cancer	0.00075	0.00283	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2C19—prostate cancer	0.000746	0.00282	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTT1—prostate cancer	0.000728	0.00275	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000724	0.00273	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITGA6—prostate cancer	0.000723	0.00273	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2A6—prostate cancer	0.000719	0.00272	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—CLU—prostate cancer	0.000689	0.0026	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CLU—prostate cancer	0.000689	0.0026	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP17A1—prostate cancer	0.000689	0.0026	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CD9—prostate cancer	0.000679	0.00257	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—NCOA2—prostate cancer	0.000657	0.00248	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000645	0.00244	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—GRB7—prostate cancer	0.00063	0.00238	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GRB7—prostate cancer	0.00063	0.00238	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000617	0.00233	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CLU—prostate cancer	0.000614	0.00232	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP2E1—prostate cancer	0.000612	0.00231	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—PLCB2—prostate cancer	0.000611	0.00231	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GNG5—prostate cancer	0.0006	0.00227	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—GNG5—prostate cancer	0.0006	0.00227	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP3A4—prostate cancer	0.00059	0.00223	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—SLC22A1—prostate cancer	0.000583	0.0022	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP1B1—prostate cancer	0.00058	0.00219	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GRB7—prostate cancer	0.000562	0.00212	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GGT1—prostate cancer	0.000562	0.00212	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—GNG5—prostate cancer	0.000555	0.00209	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—NCOA1—prostate cancer	0.000553	0.00209	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP19A1—prostate cancer	0.000545	0.00206	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GNG5—prostate cancer	0.000535	0.00202	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—RXRA—prostate cancer	0.000526	0.00199	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PRKACB—prostate cancer	0.000511	0.00193	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PRKACB—prostate cancer	0.000511	0.00193	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—COMT—prostate cancer	0.000507	0.00191	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTP1—prostate cancer	0.000505	0.00191	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—THBS1—prostate cancer	0.000498	0.00188	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—THBS1—prostate cancer	0.000498	0.00188	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—ACHE—prostate cancer	0.000494	0.00187	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PRKCZ—prostate cancer	0.000482	0.00182	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PRKCZ—prostate cancer	0.000482	0.00182	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NOS3—prostate cancer	0.000482	0.00182	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—PRKACB—prostate cancer	0.000473	0.00179	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTM1—prostate cancer	0.000464	0.00175	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PRKACB—prostate cancer	0.000456	0.00172	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000449	0.0017	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—THBS1—prostate cancer	0.000444	0.00168	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP1A1—prostate cancer	0.000439	0.00166	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HAO1—prostate cancer	0.000434	0.00164	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PRKCZ—prostate cancer	0.00043	0.00162	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PRKCQ—prostate cancer	0.00041	0.00155	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PRKCQ—prostate cancer	0.00041	0.00155	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLAUR—prostate cancer	0.000405	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PLAUR—prostate cancer	0.000405	0.00153	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—VAV3—prostate cancer	0.000376	0.00142	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—VAV3—prostate cancer	0.000376	0.00142	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PRKCQ—prostate cancer	0.000365	0.00138	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITPR1—prostate cancer	0.000365	0.00138	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITPR1—prostate cancer	0.000365	0.00138	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PLAUR—prostate cancer	0.000361	0.00136	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TST—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CBR1—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CSAD—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ADI1—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSAT1—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GRHL1—prostate cancer	0.000354	0.00134	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—COMT—prostate cancer	0.000344	0.0013	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—VAV3—prostate cancer	0.000335	0.00127	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UGT2B15—prostate cancer	0.000329	0.00124	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UGT2B17—prostate cancer	0.000329	0.00124	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GRHPR—prostate cancer	0.000329	0.00124	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CKMT2—prostate cancer	0.000329	0.00124	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITPR1—prostate cancer	0.000325	0.00123	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITGB3—prostate cancer	0.000323	0.00122	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITGB3—prostate cancer	0.000323	0.00122	CbGpPWpGaD
Nitroglycerin—Infection—Etoposide—prostate cancer	0.000312	0.00059	CcSEcCtD
Nitroglycerin—Mental disorder—Capecitabine—prostate cancer	0.000312	0.000589	CcSEcCtD
Nitroglycerin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000311	0.000588	CcSEcCtD
Nitroglycerin—Erythema—Capecitabine—prostate cancer	0.00031	0.000585	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—MBTPS1—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SULT2B1—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—RFK—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AOX1—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTM3—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NAGLU—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PGAM2—prostate cancer	0.000309	0.00117	CbGpPWpGaD
Nitroglycerin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000309	0.000583	CcSEcCtD
Nitroglycerin—Tachycardia—Etoposide—prostate cancer	0.000307	0.000579	CcSEcCtD
Nitroglycerin—Skin disorder—Etoposide—prostate cancer	0.000305	0.000576	CcSEcCtD
Nitroglycerin—Nausea—Goserelin—prostate cancer	0.000304	0.000574	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Etoposide—prostate cancer	0.000304	0.000574	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000303	0.000572	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—prostate cancer	0.000302	0.00057	CcSEcCtD
Nitroglycerin—Nausea—Conjugated Estrogens—prostate cancer	0.000301	0.000568	CcSEcCtD
Nitroglycerin—Urticaria—Mitoxantrone—prostate cancer	0.0003	0.000567	CcSEcCtD
Nitroglycerin—Hypersensitivity—Estradiol—prostate cancer	0.000299	0.000564	CcSEcCtD
Nitroglycerin—Body temperature increased—Mitoxantrone—prostate cancer	0.000299	0.000564	CcSEcCtD
Nitroglycerin—Abdominal pain—Mitoxantrone—prostate cancer	0.000299	0.000564	CcSEcCtD
Nitroglycerin—Flushing—Prednisone—prostate cancer	0.000294	0.000556	CcSEcCtD
Nitroglycerin—Hypotension—Etoposide—prostate cancer	0.000294	0.000554	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SRD5A2—prostate cancer	0.000293	0.00111	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NAT1—prostate cancer	0.000293	0.00111	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP3A43—prostate cancer	0.000293	0.00111	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AMACR—prostate cancer	0.000293	0.00111	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—DEGS1—prostate cancer	0.000293	0.00111	CbGpPWpGaD
Nitroglycerin—Vision blurred—Capecitabine—prostate cancer	0.000292	0.000551	CcSEcCtD
Nitroglycerin—Asthenia—Estradiol—prostate cancer	0.000291	0.000549	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—ITGB3—prostate cancer	0.000288	0.00109	CbGpPWpGaD
Nitroglycerin—Angiopathy—Prednisone—prostate cancer	0.000288	0.000543	CcSEcCtD
Nitroglycerin—Syncope—Docetaxel—prostate cancer	0.000287	0.000542	CcSEcCtD
Nitroglycerin—Pruritus—Estradiol—prostate cancer	0.000287	0.000542	CcSEcCtD
Nitroglycerin—Immune system disorder—Prednisone—prostate cancer	0.000286	0.000541	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PLAU—prostate cancer	0.000284	0.00107	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PLAU—prostate cancer	0.000284	0.00107	CbGpPWpGaD
Nitroglycerin—Arrhythmia—Prednisone—prostate cancer	0.000283	0.000535	CcSEcCtD
Nitroglycerin—Palpitations—Docetaxel—prostate cancer	0.000283	0.000534	CcSEcCtD
Nitroglycerin—Paraesthesia—Etoposide—prostate cancer	0.000282	0.000533	CcSEcCtD
Nitroglycerin—Loss of consciousness—Docetaxel—prostate cancer	0.000281	0.000531	CcSEcCtD
Nitroglycerin—Dyspnoea—Etoposide—prostate cancer	0.00028	0.000529	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—HSD17B1—prostate cancer	0.000279	0.00106	CbGpPWpGaD
Nitroglycerin—Somnolence—Etoposide—prostate cancer	0.000279	0.000528	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—prostate cancer	0.000279	0.000527	CcSEcCtD
Nitroglycerin—Vertigo—Capecitabine—prostate cancer	0.000278	0.000526	CcSEcCtD
Nitroglycerin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000278	0.000526	CcSEcCtD
Nitroglycerin—Syncope—Capecitabine—prostate cancer	0.000278	0.000525	CcSEcCtD
Nitroglycerin—Mental disorder—Prednisone—prostate cancer	0.000278	0.000524	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—CAV1—prostate cancer	0.000278	0.00105	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CAV1—prostate cancer	0.000278	0.00105	CbGpPWpGaD
Nitroglycerin—Drowsiness—Epirubicin—prostate cancer	0.000276	0.000522	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—prostate cancer	0.000276	0.000522	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—prostate cancer	0.000276	0.000522	CcSEcCtD
Nitroglycerin—Erythema—Prednisone—prostate cancer	0.000276	0.000521	CcSEcCtD
Nitroglycerin—Palpitations—Capecitabine—prostate cancer	0.000274	0.000517	CcSEcCtD
Nitroglycerin—Loss of consciousness—Capecitabine—prostate cancer	0.000272	0.000514	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000271	0.000512	CcSEcCtD
Nitroglycerin—Asthenia—Mitoxantrone—prostate cancer	0.000271	0.000512	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.00027	0.000511	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—prostate cancer	0.000269	0.000508	CcSEcCtD
Nitroglycerin—Dizziness—Estradiol—prostate cancer	0.000268	0.000506	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—prostate cancer	0.000265	0.0005	CcSEcCtD
Nitroglycerin—Confusional state—Docetaxel—prostate cancer	0.000263	0.000497	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000262	0.000495	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Docetaxel—prostate cancer	0.000261	0.000493	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisone—prostate cancer	0.00026	0.000491	CcSEcCtD
Nitroglycerin—Infection—Docetaxel—prostate cancer	0.000259	0.00049	CcSEcCtD
Nitroglycerin—Feeling abnormal—Etoposide—prostate cancer	0.000259	0.000489	CcSEcCtD
Nitroglycerin—Vomiting—Estradiol—prostate cancer	0.000258	0.000487	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Etoposide—prostate cancer	0.000257	0.000485	CcSEcCtD
Nitroglycerin—Shock—Docetaxel—prostate cancer	0.000257	0.000485	CcSEcCtD
Nitroglycerin—Nervous system disorder—Docetaxel—prostate cancer	0.000256	0.000484	CcSEcCtD
Nitroglycerin—Rash—Estradiol—prostate cancer	0.000256	0.000483	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—prostate cancer	0.000255	0.000483	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—prostate cancer	0.000255	0.000483	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—prostate cancer	0.000255	0.000483	CcSEcCtD
Nitroglycerin—Dermatitis—Estradiol—prostate cancer	0.000255	0.000482	CcSEcCtD
Nitroglycerin—Confusional state—Capecitabine—prostate cancer	0.000255	0.000481	CcSEcCtD
Nitroglycerin—Tachycardia—Docetaxel—prostate cancer	0.000255	0.000481	CcSEcCtD
Nitroglycerin—Headache—Estradiol—prostate cancer	0.000254	0.00048	CcSEcCtD
Nitroglycerin—Skin disorder—Docetaxel—prostate cancer	0.000254	0.000479	CcSEcCtD
Nitroglycerin—Agitation—Prednisone—prostate cancer	0.000254	0.000479	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PLAU—prostate cancer	0.000253	0.000957	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CG—prostate cancer	0.000253	0.000955	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CG—prostate cancer	0.000253	0.000955	CbGpPWpGaD
Nitroglycerin—Bradycardia—Epirubicin—prostate cancer	0.000252	0.000477	CcSEcCtD
Nitroglycerin—Angioedema—Prednisone—prostate cancer	0.000252	0.000476	CcSEcCtD
Nitroglycerin—Infection—Capecitabine—prostate cancer	0.000251	0.000474	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—EGF—prostate cancer	0.00025	0.000944	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—EGF—prostate cancer	0.00025	0.000944	CbGpPWpGaD
Nitroglycerin—Urticaria—Etoposide—prostate cancer	0.00025	0.000471	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—B4GALT4—prostate cancer	0.000249	0.000941	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HPGD—prostate cancer	0.000249	0.000941	CbGpPWpGaD
Nitroglycerin—Stomatitis—Doxorubicin—prostate cancer	0.000249	0.00047	CcSEcCtD
Nitroglycerin—Shock—Capecitabine—prostate cancer	0.000249	0.00047	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—prostate cancer	0.000249	0.000469	CcSEcCtD
Nitroglycerin—Body temperature increased—Etoposide—prostate cancer	0.000248	0.000469	CcSEcCtD
Nitroglycerin—Abdominal pain—Etoposide—prostate cancer	0.000248	0.000469	CcSEcCtD
Nitroglycerin—Nervous system disorder—Capecitabine—prostate cancer	0.000248	0.000468	CcSEcCtD
Nitroglycerin—Vertigo—Prednisone—prostate cancer	0.000248	0.000468	CcSEcCtD
Nitroglycerin—Syncope—Prednisone—prostate cancer	0.000247	0.000467	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—CAV1—prostate cancer	0.000247	0.000934	CbGpPWpGaD
Nitroglycerin—Tachycardia—Capecitabine—prostate cancer	0.000247	0.000466	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—prostate cancer	0.000246	0.000465	CcSEcCtD
Nitroglycerin—Skin disorder—Capecitabine—prostate cancer	0.000246	0.000464	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—prostate cancer	0.000245	0.000463	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Capecitabine—prostate cancer	0.000244	0.000462	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—prostate cancer	0.000244	0.000461	CcSEcCtD
Nitroglycerin—Hypotension—Docetaxel—prostate cancer	0.000244	0.000461	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisone—prostate cancer	0.000243	0.000458	CcSEcCtD
Nitroglycerin—Nausea—Estradiol—prostate cancer	0.000241	0.000455	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00024	0.000908	CbGpPWpGaD
Nitroglycerin—Vomiting—Mitoxantrone—prostate cancer	0.00024	0.000454	CcSEcCtD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—prostate cancer	0.00024	0.000907	CbGpPWpGaD
Nitroglycerin—Visual impairment—Epirubicin—prostate cancer	0.000239	0.000451	CcSEcCtD
Nitroglycerin—Rash—Mitoxantrone—prostate cancer	0.000238	0.00045	CcSEcCtD
Nitroglycerin—Dermatitis—Mitoxantrone—prostate cancer	0.000238	0.000449	CcSEcCtD
Nitroglycerin—Headache—Mitoxantrone—prostate cancer	0.000237	0.000447	CcSEcCtD
Nitroglycerin—Hypotension—Capecitabine—prostate cancer	0.000236	0.000446	CcSEcCtD
Nitroglycerin—Paraesthesia—Docetaxel—prostate cancer	0.000234	0.000443	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—CREBBP—prostate cancer	0.000234	0.000885	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—CREBBP—prostate cancer	0.000234	0.000885	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TNFRSF21—prostate cancer	0.000234	0.000885	CbGpPWpGaD
Nitroglycerin—Bradycardia—Doxorubicin—prostate cancer	0.000233	0.000441	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000233	0.000441	CcSEcCtD
Nitroglycerin—Dyspnoea—Docetaxel—prostate cancer	0.000233	0.00044	CcSEcCtD
Nitroglycerin—Somnolence—Docetaxel—prostate cancer	0.000232	0.000438	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IGF1—prostate cancer	0.000231	0.000874	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IGF1—prostate cancer	0.000231	0.000874	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Etoposide—prostate cancer	0.000231	0.000437	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—prostate cancer	0.00023	0.000435	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—prostate cancer	0.00023	0.000435	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—prostate cancer	0.00023	0.000434	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CYP7B1—prostate cancer	0.000228	0.000861	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—MTAP—prostate cancer	0.000228	0.000861	CbGpPWpGaD
Nitroglycerin—Pharyngitis—Doxorubicin—prostate cancer	0.000228	0.00043	CcSEcCtD
Nitroglycerin—Paraesthesia—Capecitabine—prostate cancer	0.000227	0.000429	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—prostate cancer	0.000226	0.000427	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000225	0.000426	CcSEcCtD
Nitroglycerin—Asthenia—Etoposide—prostate cancer	0.000225	0.000426	CcSEcCtD
Nitroglycerin—Dyspnoea—Capecitabine—prostate cancer	0.000225	0.000426	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CG—prostate cancer	0.000225	0.000851	CbGpPWpGaD
Nitroglycerin—Anaphylactic shock—Prednisone—prostate cancer	0.000225	0.000425	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—prostate cancer	0.000225	0.000425	CcSEcCtD
Nitroglycerin—Nausea—Mitoxantrone—prostate cancer	0.000224	0.000424	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—prostate cancer	0.000224	0.000423	CcSEcCtD
Nitroglycerin—Infection—Prednisone—prostate cancer	0.000224	0.000423	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—prostate cancer	0.000223	0.000422	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—EGF—prostate cancer	0.000223	0.000841	CbGpPWpGaD
Nitroglycerin—Pruritus—Etoposide—prostate cancer	0.000222	0.00042	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CD—prostate cancer	0.000222	0.000839	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CD—prostate cancer	0.000222	0.000839	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SULT1E1—prostate cancer	0.000222	0.000839	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SRD5A1—prostate cancer	0.000222	0.000839	CbGpPWpGaD
Nitroglycerin—Shock—Prednisone—prostate cancer	0.000222	0.000418	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—prostate cancer	0.000221	0.000418	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—prostate cancer	0.000221	0.000417	CcSEcCtD
Nitroglycerin—Nervous system disorder—Prednisone—prostate cancer	0.000221	0.000417	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—SERPINE1—prostate cancer	0.00022	0.00083	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SERPINE1—prostate cancer	0.00022	0.00083	CbGpPWpGaD
Nitroglycerin—Tachycardia—Prednisone—prostate cancer	0.00022	0.000415	CcSEcCtD
Nitroglycerin—Skin disorder—Prednisone—prostate cancer	0.000219	0.000413	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000218	0.000412	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisone—prostate cancer	0.000218	0.000411	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—prostate cancer	0.000217	0.00041	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—prostate cancer	0.000216	0.000408	CcSEcCtD
Nitroglycerin—Feeling abnormal—Docetaxel—prostate cancer	0.000215	0.000406	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Docetaxel—prostate cancer	0.000214	0.000403	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—prostate cancer	0.000213	0.000402	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—prostate cancer	0.000213	0.000402	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ACSL4—prostate cancer	0.000212	0.0008	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HSD17B3—prostate cancer	0.000212	0.0008	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—NOS3—prostate cancer	0.00021	0.000793	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—NOS3—prostate cancer	0.00021	0.000793	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—CREBBP—prostate cancer	0.000209	0.000789	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Capecitabine—prostate cancer	0.000208	0.000393	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—prostate cancer	0.000208	0.000393	CcSEcCtD
Nitroglycerin—Dizziness—Etoposide—prostate cancer	0.000208	0.000392	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—prostate cancer	0.000207	0.000391	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Capecitabine—prostate cancer	0.000207	0.00039	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—prostate cancer	0.000207	0.00039	CcSEcCtD
Nitroglycerin—Abdominal pain—Docetaxel—prostate cancer	0.000206	0.00039	CcSEcCtD
Nitroglycerin—Body temperature increased—Docetaxel—prostate cancer	0.000206	0.00039	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IGF1—prostate cancer	0.000206	0.000779	CbGpPWpGaD
Nitroglycerin—Arrhythmia—Doxorubicin—prostate cancer	0.000205	0.000387	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—JAK2—prostate cancer	0.000204	0.00077	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—JAK2—prostate cancer	0.000204	0.00077	CbGpPWpGaD
Nitroglycerin—Vision blurred—Epirubicin—prostate cancer	0.000203	0.000384	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ARG2—prostate cancer	0.000203	0.000767	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UMPS—prostate cancer	0.000203	0.000767	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PHGDH—prostate cancer	0.000203	0.000767	CbGpPWpGaD
Nitroglycerin—Paraesthesia—Prednisone—prostate cancer	0.000202	0.000382	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—prostate cancer	0.000201	0.00038	CcSEcCtD
Nitroglycerin—Urticaria—Capecitabine—prostate cancer	0.000201	0.000379	CcSEcCtD
Nitroglycerin—Body temperature increased—Capecitabine—prostate cancer	0.0002	0.000377	CcSEcCtD
Nitroglycerin—Abdominal pain—Capecitabine—prostate cancer	0.0002	0.000377	CcSEcCtD
Nitroglycerin—Vomiting—Etoposide—prostate cancer	0.0002	0.000377	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—prostate cancer	0.0002	0.000377	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—LDHB—prostate cancer	0.000199	0.000752	CbGpPWpGaD
Nitroglycerin—Agitation—Epirubicin—prostate cancer	0.000198	0.000375	CcSEcCtD
Nitroglycerin—Rash—Etoposide—prostate cancer	0.000198	0.000374	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CD—prostate cancer	0.000198	0.000748	CbGpPWpGaD
Nitroglycerin—Dermatitis—Etoposide—prostate cancer	0.000198	0.000374	CcSEcCtD
Nitroglycerin—Headache—Etoposide—prostate cancer	0.000197	0.000372	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—SERPINE1—prostate cancer	0.000196	0.00074	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP3A5—prostate cancer	0.000195	0.000738	CbGpPWpGaD
Nitroglycerin—Vertigo—Epirubicin—prostate cancer	0.000194	0.000366	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CB—prostate cancer	0.000194	0.000732	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CB—prostate cancer	0.000194	0.000732	CbGpPWpGaD
Nitroglycerin—Syncope—Epirubicin—prostate cancer	0.000194	0.000365	CcSEcCtD
Nitroglycerin—Hypersensitivity—Docetaxel—prostate cancer	0.000192	0.000363	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—prostate cancer	0.000191	0.00036	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—prostate cancer	0.00019	0.000358	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—TCN2—prostate cancer	0.000189	0.000713	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTA3—prostate cancer	0.000189	0.000713	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PDHA1—prostate cancer	0.000189	0.000713	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—UCP3—prostate cancer	0.000189	0.000713	CbGpPWpGaD
Nitroglycerin—Vision blurred—Doxorubicin—prostate cancer	0.000188	0.000355	CcSEcCtD
Nitroglycerin—Asthenia—Docetaxel—prostate cancer	0.000187	0.000354	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—NOS3—prostate cancer	0.000187	0.000707	CbGpPWpGaD
Nitroglycerin—Nausea—Etoposide—prostate cancer	0.000187	0.000352	CcSEcCtD
Nitroglycerin—Hypersensitivity—Capecitabine—prostate cancer	0.000186	0.000352	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisone—prostate cancer	0.000186	0.00035	CcSEcCtD
Nitroglycerin—Pruritus—Docetaxel—prostate cancer	0.000185	0.000349	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Prednisone—prostate cancer	0.000184	0.000348	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—MDM2—prostate cancer	0.000184	0.000695	CbGpPWpGaD
Nitroglycerin—Agitation—Doxorubicin—prostate cancer	0.000183	0.000347	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000182	0.000345	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—JAK2—prostate cancer	0.000182	0.000687	CbGpPWpGaD
Nitroglycerin—Asthenia—Capecitabine—prostate cancer	0.000181	0.000343	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—HSD3B1—prostate cancer	0.00018	0.00068	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC22A3—prostate cancer	0.00018	0.00068	CbGpPWpGaD
Nitroglycerin—Vertigo—Doxorubicin—prostate cancer	0.000179	0.000339	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—prostate cancer	0.000179	0.000338	CcSEcCtD
Nitroglycerin—Urticaria—Prednisone—prostate cancer	0.000179	0.000338	CcSEcCtD
Nitroglycerin—Pruritus—Capecitabine—prostate cancer	0.000179	0.000338	CcSEcCtD
Nitroglycerin—Abdominal pain—Prednisone—prostate cancer	0.000178	0.000336	CcSEcCtD
Nitroglycerin—Body temperature increased—Prednisone—prostate cancer	0.000178	0.000336	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IL2—prostate cancer	0.000178	0.000672	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IL2—prostate cancer	0.000178	0.000672	CbGpPWpGaD
Nitroglycerin—Confusional state—Epirubicin—prostate cancer	0.000178	0.000335	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—prostate cancer	0.000176	0.000333	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—prostate cancer	0.000176	0.000333	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—prostate cancer	0.000175	0.000331	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—prostate cancer	0.000175	0.00033	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—prostate cancer	0.000173	0.000327	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—prostate cancer	0.000173	0.000326	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—TBXAS1—prostate cancer	0.000173	0.000652	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTA4—prostate cancer	0.000173	0.000652	CbGpPWpGaD
Nitroglycerin—Dizziness—Docetaxel—prostate cancer	0.000173	0.000326	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CB—prostate cancer	0.000173	0.000652	CbGpPWpGaD
Nitroglycerin—Tachycardia—Epirubicin—prostate cancer	0.000172	0.000325	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—prostate cancer	0.000171	0.000323	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—prostate cancer	0.00017	0.000322	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000169	0.000319	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GSTA2—prostate cancer	0.000168	0.000636	CbGpPWpGaD
Nitroglycerin—Dizziness—Capecitabine—prostate cancer	0.000167	0.000316	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SULT1A1—prostate cancer	0.000166	0.000628	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCG5—prostate cancer	0.000166	0.000628	CbGpPWpGaD
Nitroglycerin—Vomiting—Docetaxel—prostate cancer	0.000166	0.000314	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisone—prostate cancer	0.000166	0.000313	CcSEcCtD
Nitroglycerin—Rash—Docetaxel—prostate cancer	0.000165	0.000311	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—prostate cancer	0.000165	0.000311	CcSEcCtD
Nitroglycerin—Dermatitis—Docetaxel—prostate cancer	0.000164	0.000311	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—prostate cancer	0.000164	0.00031	CcSEcCtD
Nitroglycerin—Headache—Docetaxel—prostate cancer	0.000164	0.000309	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—prostate cancer	0.000163	0.000308	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GSTA1—prostate cancer	0.000162	0.000613	CbGpPWpGaD
Nitroglycerin—Infection—Doxorubicin—prostate cancer	0.000162	0.000306	CcSEcCtD
Nitroglycerin—Asthenia—Prednisone—prostate cancer	0.000162	0.000305	CcSEcCtD
Nitroglycerin—Vomiting—Capecitabine—prostate cancer	0.000161	0.000304	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—NAT2—prostate cancer	0.000161	0.000606	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTO1—prostate cancer	0.000161	0.000606	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HSD3B2—prostate cancer	0.000161	0.000606	CbGpPWpGaD
Nitroglycerin—Shock—Doxorubicin—prostate cancer	0.00016	0.000303	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—prostate cancer	0.00016	0.000302	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—EP300—prostate cancer	0.00016	0.000603	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—EP300—prostate cancer	0.00016	0.000603	CbGpPWpGaD
Nitroglycerin—Rash—Capecitabine—prostate cancer	0.000159	0.000301	CcSEcCtD
Nitroglycerin—Pruritus—Prednisone—prostate cancer	0.000159	0.000301	CcSEcCtD
Nitroglycerin—Dermatitis—Capecitabine—prostate cancer	0.000159	0.000301	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—prostate cancer	0.000159	0.0003	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IL2—prostate cancer	0.000159	0.000599	CbGpPWpGaD
Nitroglycerin—Headache—Capecitabine—prostate cancer	0.000158	0.000299	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—prostate cancer	0.000158	0.000299	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—prostate cancer	0.000158	0.000299	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—prostate cancer	0.000158	0.000298	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—prostate cancer	0.000157	0.000297	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—prostate cancer	0.000157	0.000296	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—SRC—prostate cancer	0.000155	0.000586	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—SRC—prostate cancer	0.000155	0.000586	CbGpPWpGaD
Nitroglycerin—Nausea—Docetaxel—prostate cancer	0.000155	0.000293	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PLCB2—prostate cancer	0.000154	0.000581	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2C18—prostate cancer	0.000154	0.000581	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—LRP2—prostate cancer	0.000154	0.000581	CbGpPWpGaD
Nitroglycerin—Hypotension—Doxorubicin—prostate cancer	0.000152	0.000288	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000152	0.000287	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—VEGFA—prostate cancer	0.000151	0.000571	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—VEGFA—prostate cancer	0.000151	0.000571	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—P4HB—prostate cancer	0.000151	0.00057	CbGpPWpGaD
Nitroglycerin—Nausea—Capecitabine—prostate cancer	0.00015	0.000284	CcSEcCtD
Nitroglycerin—Dizziness—Prednisone—prostate cancer	0.000149	0.000281	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC22A1—prostate cancer	0.000147	0.000555	CbGpPWpGaD
Nitroglycerin—Paraesthesia—Doxorubicin—prostate cancer	0.000146	0.000276	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—prostate cancer	0.000145	0.000274	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—prostate cancer	0.000145	0.000274	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—prostate cancer	0.000145	0.000274	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—prostate cancer	0.000144	0.000272	CcSEcCtD
Nitroglycerin—Vomiting—Prednisone—prostate cancer	0.000143	0.00027	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SULT2A1—prostate cancer	0.000143	0.00054	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—EP300—prostate cancer	0.000142	0.000537	CbGpPWpGaD
Nitroglycerin—Rash—Prednisone—prostate cancer	0.000142	0.000268	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisone—prostate cancer	0.000142	0.000268	CcSEcCtD
Nitroglycerin—Headache—Prednisone—prostate cancer	0.000141	0.000266	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—MED12—prostate cancer	0.000141	0.000532	CbGpPWpGaD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000141	0.000266	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—prostate cancer	0.00014	0.000264	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GNG5—prostate cancer	0.00014	0.000527	CbGpPWpGaD
Nitroglycerin—Body temperature increased—Epirubicin—prostate cancer	0.000139	0.000263	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—prostate cancer	0.000139	0.000263	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—TGFB1—prostate cancer	0.000139	0.000524	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TGFB1—prostate cancer	0.000139	0.000524	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—SRC—prostate cancer	0.000138	0.000523	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—VEGFA—prostate cancer	0.000135	0.000509	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NCOA3—prostate cancer	0.000135	0.000508	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Doxorubicin—prostate cancer	0.000134	0.000254	CcSEcCtD
Nitroglycerin—Nausea—Prednisone—prostate cancer	0.000134	0.000253	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000133	0.000252	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—prostate cancer	0.00013	0.000245	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—prostate cancer	0.000129	0.000244	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—prostate cancer	0.000129	0.000243	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—prostate cancer	0.000129	0.000243	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—KRAS—prostate cancer	0.000129	0.000486	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—KRAS—prostate cancer	0.000129	0.000486	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—HPGDS—prostate cancer	0.000128	0.000485	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2C19—prostate cancer	0.000128	0.000482	CbGpPWpGaD
Nitroglycerin—Asthenia—Epirubicin—prostate cancer	0.000126	0.000239	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—prostate cancer	0.000125	0.000235	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GSTT1—prostate cancer	0.000124	0.00047	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ACHE—prostate cancer	0.000124	0.00047	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TGFB1—prostate cancer	0.000124	0.000467	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2A6—prostate cancer	0.000123	0.000465	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Doxorubicin—prostate cancer	0.00012	0.000227	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—AKR1C3—prostate cancer	0.00012	0.000452	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PRKACB—prostate cancer	0.000119	0.00045	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CA—prostate cancer	0.000118	0.000446	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CA—prostate cancer	0.000118	0.000446	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP17A1—prostate cancer	0.000118	0.000445	CbGpPWpGaD
Nitroglycerin—Asthenia—Doxorubicin—prostate cancer	0.000117	0.000221	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—prostate cancer	0.000116	0.00022	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—prostate cancer	0.000115	0.000218	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—KRAS—prostate cancer	0.000115	0.000433	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TP53—prostate cancer	0.000114	0.000432	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TP53—prostate cancer	0.000114	0.000432	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NCOA2—prostate cancer	0.000112	0.000424	CbGpPWpGaD
Nitroglycerin—Vomiting—Epirubicin—prostate cancer	0.000112	0.000211	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—prostate cancer	0.000111	0.00021	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—prostate cancer	0.000111	0.00021	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—prostate cancer	0.00011	0.000208	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—prostate cancer	0.000108	0.000204	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC5A5—prostate cancer	0.000107	0.000405	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CA—prostate cancer	0.000105	0.000398	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP2E1—prostate cancer	0.000105	0.000395	CbGpPWpGaD
Nitroglycerin—Nausea—Epirubicin—prostate cancer	0.000105	0.000198	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—prostate cancer	0.000104	0.000196	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—NQO1—prostate cancer	0.000103	0.000391	CbGpPWpGaD
Nitroglycerin—Rash—Doxorubicin—prostate cancer	0.000103	0.000194	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—prostate cancer	0.000103	0.000194	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—prostate cancer	0.000102	0.000193	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—TH—prostate cancer	0.000102	0.000385	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TP53—prostate cancer	0.000102	0.000385	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP3A4—prostate cancer	0.000101	0.000381	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP1B1—prostate cancer	9.92e-05	0.000375	CbGpPWpGaD
Nitroglycerin—Nausea—Doxorubicin—prostate cancer	9.68e-05	0.000183	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—AKT1—prostate cancer	9.65e-05	0.000364	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—AKT1—prostate cancer	9.65e-05	0.000364	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GGT1—prostate cancer	9.61e-05	0.000363	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NCOA1—prostate cancer	9.46e-05	0.000357	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP19A1—prostate cancer	9.32e-05	0.000352	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—RXRA—prostate cancer	9e-05	0.00034	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—COMT—prostate cancer	8.67e-05	0.000327	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTP1—prostate cancer	8.63e-05	0.000326	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—AKT1—prostate cancer	8.6e-05	0.000325	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ITPR1—prostate cancer	8.49e-05	0.000321	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—TYMS—prostate cancer	8.02e-05	0.000303	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTM1—prostate cancer	7.93e-05	0.000299	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—LPL—prostate cancer	7.78e-05	0.000294	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP1A1—prostate cancer	7.52e-05	0.000284	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ERCC2—prostate cancer	7.45e-05	0.000282	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—MTHFR—prostate cancer	7.01e-05	0.000265	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PPARA—prostate cancer	6.87e-05	0.00026	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CAV1—prostate cancer	6.46e-05	0.000244	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CG—prostate cancer	5.89e-05	0.000222	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—INS—prostate cancer	5.57e-05	0.00021	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CREBBP—prostate cancer	5.46e-05	0.000206	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CD—prostate cancer	5.18e-05	0.000195	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—NOS3—prostate cancer	4.89e-05	0.000185	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CB—prostate cancer	4.51e-05	0.00017	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS2—prostate cancer	4.47e-05	0.000169	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTEN—prostate cancer	3.9e-05	0.000147	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—EP300—prostate cancer	3.72e-05	0.00014	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CA—prostate cancer	2.75e-05	0.000104	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—AKT1—prostate cancer	2.25e-05	8.49e-05	CbGpPWpGaD
